Comparison of Salvage Chemotherapy Regimens in Relapsed/Refractory Acute Myeloid Leukemia

被引：0
作者：
Mushtaq, Muhammad Umair [1 ,2 ]
Chaudhary, Sibgha Gull [1 ,2 ]
Michaelis, Laura C. [3 ]
Carlson, Karen-Sue B. [3 ]
Abedin, Sameem [3 ]
Runass, Lyndsey [3 ]
Fallon, Michael J. [1 ,2 ]
Harrington, Alexandra M. [4 ]
Juckett, Mark [2 ,5 ]
Hall, Aric C. [1 ,2 ]
Mattison, Ryan J. [1 ,2 ]
Atallah, Ehab L. [3 ]
Murthy, Guru Subramanian Guru [3 ]
机构：
[1] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Div Hematol Oncol, Madison, WI USA
[2] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA
[3] Med Coll Wisconsin, Dept Med, Div Hematol Oncol, Milwaukee, WI 53226 USA
[4] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA
[5] Univ Wisconsin, Sch Med & Publ Hlth, Div Hematol Oncol, Madison, WI USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-113764
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2708
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Fludarabine and cytarabine in patients with relapsed acute myeloid leukemia refractory to initial salvage therapy
    Brian McLaughlin
    Annie Im
    Anastasios Raptis
    Mounzer Agha
    Jing-Zhou Hou
    Robert Redner
    Shrina Duggal
    Yan Lin
    Clay Smith
    Michael Boyiadzis
    International Journal of Hematology, 2012, 96 : 743 - 747
  • [32] Fludarabine and cytarabine in patients with relapsed acute myeloid leukemia refractory to initial salvage therapy
    McLaughlin, Brian
    Im, Annie
    Raptis, Anastasios
    Agha, Mounzer
    Hou, Jing-Zhou
    Redner, Robert
    Duggal, Shrina
    Lin, Yan
    Smith, Clay
    Boyiadzis, Michael
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (06) : 743 - 747
  • [33] Salvage Therapy Outcomes in a Historical Cohort of Patients With Relapsed or Refractory Acute Myeloid Leukemia
    Ravandi, Farhad
    Pierce, Sherry
    Garcia-Manero, Guillermo
    Kadia, Tapan
    Jabbour, Elias
    Borthakur, Gautam
    DiNardo, Courtney D.
    Daver, Naval
    Short, Nicholas J.
    Alvarado, Yesid
    Cortes, Jorge
    Kim, Christopher
    Kelsh, Michael
    Katz, Aaron
    Williams, Richard
    Yang, Zhao
    Mehta, Bhakti
    Kantarjian, Hagop
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (11) : E871 - E882
  • [34] IDH inhibitors or chemotherapy in relapsed or refractory IDHmut acute myeloid leukemia.
    Murray, Graeme
    Bouligny, Ian Michael
    Patel, Tilak
    Doyel, Michael
    Boron, Josh
    Tran, Valerie
    Gor, Juhi
    Hang, Yiwei
    Ho, Thuy
    Zacholski, Kyle
    Venn, Chad Michael
    Alnimer, Yanal Mufeed
    Wages, Nolan
    Grant, Steven
    Maher, Keri Renee
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [35] Gemtuzumab ozogamicin in combination with intensive chemotherapy in relapsed or refractory acute myeloid leukemia
    Chantepie, Sylvain P.
    Reboursiere, Emilie
    Mear, Jean-Baptiste
    Gac, Anne-Claire
    Salaun, Veronique
    Benabed, Khaled
    Cheze, Stephane
    Johnsonansah, Hyacinthe
    Macro, Margaret
    Vilque, Jean-Pierre
    Reman, Oumedaly
    LEUKEMIA & LYMPHOMA, 2015, 56 (08) : 2326 - 2330
  • [36] Chemotherapy Cannot Replace Transplantation in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
    Li, Xiaoyu
    Chen, Baoan
    Cheng, Jian
    Lin, Min
    Zhang, Xiaoping
    Ge, Zheng
    BLOOD, 2016, 128 (22)
  • [37] Treatment for Relapsed/Refractory Acute Myeloid Leukemia
    Thol, Felicitas
    Heuser, Michael
    HEMASPHERE, 2021, 5 (06): : E572
  • [38] Treatment of Relapsed/Refractory Acute Myeloid Leukemia
    Bose, Prithviraj
    Vachhani, Pankit
    Cortes, Jorge E.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (03)
  • [39] Treatment of Relapsed/Refractory Acute Myeloid Leukemia
    Prithviraj Bose
    Pankit Vachhani
    Jorge E. Cortes
    Current Treatment Options in Oncology, 2017, 18
  • [40] Salvage therapy for refractory or relapsed acute lymphocytic leukemia
    Garcia-Manero, G
    Thomas, DA
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2001, 15 (01) : 163 - +
12345